Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Jisheng Shenqi decoction plus Huangqi acupoint injection for liver cirrhosis
ChiCTR2400080697Phase 3Not yet recruiting
- Sponsor
- Liuzhou Traditional Chinese Medicine Hospital
- Start
- Feb 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of jiawei jisheng shenqi tang and astrgalus in Cirrhosis (2 arms), sponsored by Liuzhou Traditional Chinese Medicine Hospital. Primary endpoint: Quality of life score. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
jiawei jisheng shenqi tangastrgalus
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on ChiCTR2400080697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080697.